Never | Seldom | Occasionally | Frequently | *Total no of resp. | +Non resp. | |
---|---|---|---|---|---|---|
Plagiarism | 15 (11.5%) | 39 (29.7%) | 65 (49.6%) | 12 (9.2%) | 131 | 2 |
Falsifying data | 12 (9.1%) | 40 (30.3%) | 62 (47.0%) | 18 (13.6%) | 132 | 1 |
Intentional protocol violations related to subject enrolment | 16 (12.5%) | 51 (39.8%) | 48 (37.5%) | 13 (10.2%) | 128 | 5 |
Intentional protocol violations related to procedures | 18 (14.3%) | 49 (38.9%) | 46 (36.5%) | 13 (10.3%) | 126 | 7 |
Selective dropping of data from ‘outlier’ cases | 17 (13.6%) | 41 (32.8%) | 52 (41.6%) | 15 (12.0%) | 125 | 8 |
Falsification of biosketch, resume, reference list | 29 (23%) | 52 (41.3%) | 34 (27.0%) | 11 (8.7%) | 126 | 7 |
Disagreements about authorship | 22 (16.7%) | 61(46.2%) | 39 (29.5%) | 10 (7.6%) | 132 | 1 |
Pressure from study sponsor (e.g. pharmaceutical company or device company) to engage in unethical practices | 48 (38.4%) | 42 (33.6%) | 31 (24.8%) | 4 (3.2%) | 125 | 8 |